Wednesday, July 8, 2026

pharma · Malaria · Pharmacokinetics · CNSP

CNS Pharmaceuticals

CNS Pharmaceuticals trial registry — 22 ClinicalTrials.gov studies with program phase, status, and indication context.

Houston, TX 77027, US HQ
2017 Founded
12 Employees
Public company Type
CNSP · NYSE Ticker
Company details
Status
Public
HQ
Houston, TX 77027, US
Founded
2017
Employees
12
Programs
21
Drugs
18
Patents
0
Intelligence · Clinical Trials

CNS Pharmaceuticals clinical trials

Registry index of 22 ClinicalTrials.gov studies linked to CNS Pharmaceuticals programs — each row shows trial ID, program name, phase, status, and indication.

CNS Pharmaceuticals trial registry — 22 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

8 updates

Latest clinical program signals indexed for CNS Pharmaceuticals.

  1. 9941 — Phase 2

    Clinical update
  2. Sertraline+Antibiotic (penicillin/azithromycin) — Phase 2

    Clinical update
  3. PRA — Phase 1

    Clinical update
  4. DAB — Phase 1

    Clinical update
  5. (+)-SJ000557733 — Phase 1

    Clinical update
  6. Berubicin hydrochloride, Cecenu® 40 mg Kapsel — Phase 2

    Clinical update
  7. vitamin C — Phase 2

    Clinical update
  8. rTMS (repetitive transcranial magnetic stimulation) — Phase 2

    Clinical update

Trial registry

22 studies